Medtronic MiniMed 630G System
Medtronic Minimed · Decision date Oct 16, 2025
What did the FDA decide?
FDA records P150001/S110 as a supplement to PMA P150001, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 16, 2025.
FDA approval order statement
addition of a new supplier for a critical component of the Guardian Sensor (3) and Guardian 4 Sensor. The Guardian Sensor (3) is a component of the MiniMed 670G, MiniMed 770G, and MiniMed 780G Systems, MiniMed 630G System with Smart Guard, and Guardian Connect Systems. The Guardian 4 Sensor is a component of the MiniMed 780G System
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Clinical Chemistry
- Decision date
- Oct 16, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P150001/S110
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Minimed
- Product code
- OZO
- Decision code
- OK30
- Decision date
- Oct 16, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated insulin dosing , threshold suspend.
- Applicant
- Medtronic Minimed
- Product code
- OZO
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P150001/S110 received
Application receipt date recorded by FDA.
P150001/S110 · FDA decision
30-Day Notice
P150001/S111 · Related supplement
Medtronic MiniMed 630G System with Guardian Sensor (3); Guardian Sensor (3) Transfer to MPROC
Timeline entries are records held by MedtechLedger for P150001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Minimed | PMA supplement | Jul 21, 2026 | FDA |
Explore the linked device profile
Other records with product code OZO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Enlite SensorP120010/S144 | Medtronic, Inc. | PMA supplement | Jul 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Minimed
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 18000 Devonshire St., Northridge, CA, 91325
Sources and methodology
- Original FDA record: P150001/S110
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
